Filter
2455
Filtered Results: 2455
Text search:
ART
drugs
Featured
Recommendations
193
New Publications
746
Language
Document type
No document type
1798
Studies & Reports
235
Guidelines
219
Manuals
79
Strategic & Response Plan
34
Training Material
32
Fact sheets
30
Infographics
12
Situation Updates
9
Brochures
4
Resource Platforms
3
Countries / Regions
India
150
Kenya
91
South Africa
76
Zambia
69
Tanzania
65
Ethiopia
61
Malawi
59
Nigeria
52
Uganda
49
Western and Central Europe
48
Nepal
46
Rwanda
42
Liberia
38
Myanmar / Burma
38
Lesotho
35
Ghana
35
Global
35
Namibia
35
Ukraine
31
Africa
31
Bangladesh
28
Sierra Leone
27
Zimbabwe
25
Asia
25
Eastern Europe
25
Latin America and the Carribbean
22
Cambodia
21
Botswana
20
Senegal
17
Germany
17
Philippines
16
Indonesia
15
Mozambique
14
South–East Asia Region
14
Eswatini/ Swaziland
14
Albania
11
Venezuela
10
Brazil
10
Russia
10
Congo, Democratic Republic of
9
Cameroon
8
Tajikistan
7
Syria
7
Colombia
6
Burkina Faso
6
Haiti
6
Paraguay
6
Georgia
6
Pakistan
6
Thailand
5
East and Southern Africa
5
Yemen
5
South Sudan
5
Benin
4
Afghanistan
4
Guinea
4
Armenia
4
West and Central Africa
4
Middle East and North Africa
4
Argentina
4
Romania
4
Estonia
3
USA
3
Eastern Europe and Central Asia
3
Vietnam
3
Moldova
3
Sudan
3
Central African Republic
3
Bhutan
3
North Macedonia
2
Timor Leste/ East Timor
2
Serbia
2
China
2
Uzbekistan
2
Peru
2
Western Pacific Region
2
Bolivia
2
Lebanon
2
Papua New Guinea
2
Sri Lanka
2
Palestine
2
Poland
2
Somalia
2
Ecuador
2
North Korea
1
Switzerland
1
Mexico
1
El Salvador
1
Australia
1
Gambia
1
Chile
1
Iran
1
Canada
1
Laos
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Hungary
1
Lithuania
1
Jordan
1
Saudi Arabia
1
Uruguay
1
Turkmenistan
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Egypt
1
Greece
1
Mali
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1102
Clinical Guidelines
192
Women & Child Health
83
Public Health
66
Capacity Building
56
Key Resources
38
Pharmacy & Technologies
20
Annual Report MEDBOX
2
Toolboxes
HIV
587
TB
273
Mental Health
147
COVID-19
47
Pharmacy
47
Caregiver
45
Refugee
33
Disability
28
AMR
27
NTDs
26
Global Health Education
20
Conflict
19
Rapid Response
16
Planetary Health
15
Ebola
12
NCDs
12
Natural Hazards
10
Health Financing Toolbox
10
Social Ethics
9
Specific Hazards
4
Polio
4
Cholera
3
Zika
2
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
The resources provide both the older as well as the updated Operational Guidelines for antiretroviral therapy centres, including administrative issues, functions and establishment of centres, reporting and recording tools, measures to improve retention in HIV care, supply chain management of drugs a...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr...
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infe...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
It is essential that all people, including people living with HIV, are able to access health services and ongoing treatment. If people living with HIV who are on ART stop abruptly because they cannot access new supplies they could rapidly become unwell, drug resistance may build and the chances of o...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
